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Abstract—The standard dementia screening tool Mini Mental
State Examination (MMSE) and the standard dementia stag-
ing tool Clinical Dementia Rating Scale (CDR) are prominent
methods for answering questions whether a person might have
dementia and about the dementia severity respectively. These
methods are time consuming and require well-educated personnel
to administer. Conversely, cognitive tests, such as the Semantic
Verbal Fluency (SVF), demand little time. With this as a starting
point, we investigate the relation between SVF results and
MMSE/CDR-SOB scores. We use regression models to predict
scores based on persons’ SVF performance. Over a set of 179
patients with different degree of dementia, we achieve a mean
absolute error of of 2.2 for MMSE (range 0–30) and 1.7 for
CDR-SOB (range 0–18). True and predicted scores agree with
a Cohen’s κ of 0.76 for MMSE and 0.52 for CDR-SOB. We
conclude that our approach has potential to serve as a cheap
dementia screening, possibly even in non-clinical settings.
Index Terms—dementia, Clinical Dementia Rating Scale
(CDR), Mini Mental State Examination (MMSE), machine learn-
ing, prediction of clinical scores
I. INTRODUCTION
Alzheimer’s Disease (AD) has a significant economic im-
pact on our society: according to the World Alzheimer Report
2016, AD is about to become a trillion dollar disease by 2018
[1]. This is in addition to the unquantifiable mental, emotional,
and physical burden that AD places on people with the illness,
and their caregivers, friends, and family. AD’s is a type of de-
mentia in which the main observable symptom is characterised
by a decline in cognitive functions, notably memory, as well as
language and problem solving. While AD is the most common
organic cause of dementia, there are many other causes, such
as vascular disorders, e.g., strokes, brain tumours, traumatic
brain injuries, or fronto-temporal lobe degeneration (FTLD);
see also Figure 1. In order to quantify dementia’s severity and
prepare for its potential impact on a patient’s environment,
staging and screening tools have been developed. The Clinical
Dementia Rating scale (CDR) [2] represents internationally the
This work was partially funded by the EIT Digital Wellbeing Activity
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Fig. 1. The left panel shows the types of dementia, according to their
cause, including Fronto-Temporal Lobar Degeneration (FTLD), and Vascular
Dementia (VD); the dotted areas indicate those cases where more than one
cause underlies the disorder. The right panel shows other, mostly reversible,
causes for dementia-like symptoms.
most widely applied staging tool for assessing the disease’s
global severity. It encompasses six domains of cognitive and
functional performance: Memory, Orientation, Judgment &
Problem Solving, Community Affairs, Home & Hobbies, and
Personal Care [3]. The assessment is conducted in the form
of semi-structured interviews with the affected person and an
affiliated person/co-interviewee, e.g., a family member.
The CDR is relatively time-consuming - interviews can take
up to 90 minutes - depending on the availability of a co-
interviewee and requires significant training of the raters in
order to achieve good reliability [4].
The CDR is often used in combination with the Mini Mental
State Examination (MMSE), a common screening tool for
dementia. It takes around ten minutes and requires a trained
assessor, consists of a series of tasks that cover different forms
of cognitive functions, such as memory and attention, and is
designed to be used as a global screening tool. However, in
some applications the MMSE lacks sensitivity; especially for
early stages, its items are considered to be relatively easy and
are highly likely to result in ceiling effects [5]. Moreover, it
has been shown, that the standard MMSE might lack sufficient
intra- and interrater reliability [6].
While there are many screening tools, a reliable diagnosis
of probable dementia can only be made through in-depth
assessments, and a comprehensive combination of behavioural
(e.g., psychometric tests) and in vivo organic assessment (e.g.,
functional brain imaging). Behavioural assessments typically
consist of structured interviews and can also include a number
of well-defined tasks to assess particular aspects of cognition,
such as memory and executive function. One of these tasks
is Semantic Verbal Fluency (SVF), where the participant is
instructed to name as many members of a semantic category as
possible in a given time period. The most common category for
this task is ”animals”. Many neurocognitive diseases lead to a
reduction in the number of items produced during an SVF task,
including AD [7]–[9], Parkinson’s Disease [10], schizophrenia
[11], or focal brain lesions [12].
We argue that qualitative analysis of such a task allows for
the deduction of corresponding dementia staging and screening
scores which would allow to objectify and underpin CDR and
MMSE scores, as well as to mitigate some of their afore-
mentioned methodological caveats. In this paper, we present
an analysis method that uses SVF data to predict two test
scores, MMSE and CDR - Sum of Boxes (CDR-SOB), which
has been used as a quantitative approximation of the CDR
scale itself [2].
After reviewing related work in Section II, we outline
our approach in Section III. In Section IV, we compare
regression models for prediction of the MMSE and CDR-SOB.
We interpret predicted scores according to common clinical
thresholds and report Cohen’s κ as a reliability measure. In
Section V, we discuss how our algorithm can be leveraged for
medical human-computer interaction applications for dementia
screening, and conclude by outlining further work.
II. RELATED WORK
A. Diagnosis as a Classification Problem
The common approach for detecting signs of neurocognitive
diseases from speech is to treat it as a classification problem,
which is either binary or n-ary (with small n for a highly
restricted number of potential diseases). The degree of manual
intervention varies, from approaches that rely on manual tran-
scriptions to a completely automated speech-based screening
pipeline yielding significant discrimination results [13].
Work in this direction usually differs in means of the anal-
ysed corpora (free speech vs. cognitive tests vs. conversation),
classification scenario (healthy vs. impaired or healthy vs.
mildly impaired vs. severely impaired) and extracted features
(linguistic vs. para-linguistic).
[14] worked on recordings of picture descriptions of the
Cookie Theft Picture Description Task, extracted from the
DementiaBank corpus [15]. They discriminate individuals with
AD from healthy, age-matched, controls (HC) with an accu-
racy of 81% using linguistic and para-linguistic features. [16]
uses language modelling techniques to calculate the perplexity
of picture description tasks from DementiaBank to separate
AD and HC individuals with an accuracy of 77.1%. [17]
extracts para-linguistic features (e.g., pauses, pitch & jitter)
of picture descriptions from DementiaBank to discriminate
between AD and HC with an accuracy of 94.7%. [18] use para-
linguistic markers from recordings of people performing dif-
ferent spoken cognitive tests (countdown, picture descriptions,
sentence repetition and SVF) to classify individuals into three
groups: early AD, Mild Cognitive Impairment (MCI) and HC.
They train three binary classifiers with varying accuracies (HC
vs. MCI: 20%± 5; AD vs. MCI: 19% ± 5; HC vs. AD: 13% ±
3). [13] analyses spontaneous speech collected in a clinical set-
ting through extracting temporal and para-linguistic features to
separate HC from MCI patients. The resulting classifier yields
an F1 score of 86.2% and an accuracy of 82.4%. [19] extracted
vocal features from a sentence reading task to discriminated
between age-matched AD and HC patients with an accuracy of
84.8%. [20] uses phonetic features collected from a SVF and
the East Boston memory test (EB) to discriminate between
HC and MCI groups with an accuracy of 86.5%. Our own
group previously extracted vocal features from cognitive tests
(counting down numbers and Cookie Theft picture description)
to identify patients with AD from HC with an accuracy of 89%
±3 [21].
B. Diagnosis as a Regression Problem
Neurocognitive diseases are complex and vary in their
exact symptoms from person to person and from stage to
stage. Therefore, it might be more useful to predict scores on
screening or diagnostic tests than predicting a raw diagnosis.
This makes it easier for clinical practitioners to integrate
findings from an automatic analysis tool with the overall
clinical picture, in particular when it comes to distinguishing
between different potential causes for the same symptoms.
To our knowledge, there has been very little work on
prediction of clinical scores from audio samples. [22] used
semantic, acoustic and lexiosemantic features extracted from
DementiaBank to predict MMSE scores. Using a bivariate
dynamic Bayes net they achieved a mean absolute error (MAE)
of 3.83, which they improved to 2.91 for patients where
longitudinal data is available. The topic has received more
attention in the image processing community and multiple
authors have predicted clinical scores from brain imaging
features, e.g., average regional grey matter density and tissue
volume of MRI [23], [24]. As an example, [25] uses a
Random Forest Regressor to predict clinical scores, including
the MMSE and CDR-SOB, based on imaging data. This leads
to a best Mean Absolute Error of 1.68 for the MMSE and 0.69
for the CDR-SOB.
C. Analysis of the SVF Task
The classical measure for SVF performance is word count
per minute. In qualitative analysis of SVF performance this
count can be modelled as a combination of two components:
“mean cluster size” and “number of switches between clus-
ters”. Clusters are defined as a sequence of words that belong
to the same semantic category in a person’s mental lexicon.
Switches occur at cluster boundaries, when the person switches
to a new semantic category. Therefore, mean cluster size
is related to the mental lexicon, whereas switches indicate
executive search processes. The two measures relate to the
word count as depicted below.
Word Count = Mean Cluster Size×(Number of Switches+1)
The semantic clustering criterion is the main determiner for
both measures. An example is given below, with one switch
and two clusters: pets and farm animals.
(cat - dog) - (cow - horse)
(Cluster1) Switch1 (Cluster2)
Para-linguistic features also have been shown to be of
value in the analysis of SVF. [20] used the pseudo-syllable
rate and average pause lengths for the analysis of SVF. [26]
analysed pauses, speech rate and disfluencies in SVF. In
order to differentiate between multiple pathologies, the above
mentioned qualitative measures have been established which
serve as additional markers next to the raw fluency word count
[27], [28]. There is a broad agreement that these measures
serve as indicators for underlying cognitive processes.
Pauses can occur both within clusters, as participants search
their mental lexicon for more examples of a specific group, and
between clusters, at the time of a switch, when a participant
is searching for the next potentially productive subcategory. In
the first 10-15 seconds of the task, pauses tend to be rare, and
they typically become more frequent, and longer towards the
end of the test.
[28] cites high reliability for their clustering annotation,
and has established a list of potential semantic subcategories.
However, when analysing new material, especially from differ-
ent cultures [26], these subcategories need to be redefined and
extended. Statistical semantic analysis can automatically and
reliably provide clusters, which makes categorisation easier to
replicate. Alternative approaches have been suggested based
on statistical methods: Latent Semantic Analysis (LSA) [29],
Explicit Semantic Analysis (ESA) [30] and Neural Word
Embeddings [31].
D. MMSE and CDR as Assessment Tools
Both, MMSE and CDR-SOB, global assessment measures
are the most widely used in clinical and research settings
for dementia screening and staging its severity. Staging de-
mentia is crucial for clinical trials and the development of
effective pharmacological interventions. They are administered
and interpreted by specially trained healthcare clinicians in
order to provide appropriate patient care and to identify the
effectiveness of prescribed treatment interventions in patients
with dementia.
Inter-rater reliability for CDR is excellent (correlation coef-
ficient 0.89) [32] and content validity can be assumed, as the
six cognitive domains rated by the CDR are linked to validated
clinical diagnostic criteria for AD [33].
Each domain is rated on a 5-point scale of functioning
as follows: 0, no impairment; 0.5, questionable impairment;
1, mild impairment; 2, moderate impairment; and 3, severe
impairment (personal care is scored on a 4-point scale without
a 0.5 rating available). The global CDR score is computed via
an algorithm that weighs memory more heavily than the other
categories1. The CDR-SOB score is obtained by summing each
of the domain box scores, with scores ranging from 0 to 18
[34]. In general, the higher the score, the greater the severity
of dementia.
The CDR-SOB score has been considered a more detailed
quantitative general index than the global score and provides
more subtle information than the global CDR score in patients
with mild dementia, and a suitable tool for measuring the
response to treatment in clinical trials of AD [35]. The
advantages of the SOB method include that the CDR-SOB
scores can be treated as interval data in statistical analyses,
whereas global CDR scores are ordinal by the nature of the
algorithm approach to condensing the data. Finally, the most
significant advantage of using CDR-SOB scores for staging
dementia severity is the increased precision, allowing for
tracking changes over time [34].
The MMSE encompasses a variety of questions, requires
minimal training and takes around 10 min. The questions are
typically grouped into seven categories, representing different
cognitive functions: orientation to time (5 points), orientation
to place (5 points), registration of three words (3 points),
attention and calculation (5 points), recall of three words (3
points), language (8 points) and visual construction (1 point)
[36], [37]. Patients score between 0 and 30 points, and cutoffs
of 23/24 have typically been used to show significant cognitive
impairment.
Its validity has been proven and it is widely translated and
used [5]. The MMSE is unfortunately sometimes misunder-
stood as a diagnostic tool, when it is actually a screening test
with relatively modest sensitivity in detecting a mild degree
of cognitive impairment. It has floor and ceiling effects and
limited sensitivity to change which is becoming a particularly
important issue with the recent increased focus of researchers
on the milder stages of AD [38].
III. METHODS
A. Data
The data used for the following experiments was collected
during the Dem@Care [39] and ELEMENT [21] projects.
All participants were aged 65 or older and were recruited
through the Memory Clinic located at the Institute Claude
Pompidou in the Nice University Hospital. Speech recordings
of elderly people were collected using an automated recording
app on a tablet computer and were subsequently transcribed
following the CHAT protocol [40]. Participants were asked to
perform a battery of cognitive tests, including a 60 second
animal SVF test. Furthermore all participants completed the
MMSE and CDR. Following the clinical assessment, partici-
pants were categorised into three groups: Control participants
that complained about having subjective cognitive impairment
(SCI) but were diagnosed as cognitively healthy after the
clinical consultation, patients with MCI and patients that
were diagnosed as suffering from Alzheimer’s Disease and
related disorders (ADRD). AD diagnosis was determined using
1http://www.biostat.wustl.edu/∼adrc/cdrpgm/index.html
TABLE I
DEMOGRAPHIC DATA AND CLINICAL SCORES BY DIAGNOSTIC GROUP (MEAN ± STANDARD DEVIATION). HC=’HUMAN CONTROL’, MCI=’MILD
COGNITIVE IMPAIRMENT’, AD= ’ALZHEIMER’S DISEASE’, MD=’MIXED DEMENTIA’, VD=’VASCULAR DEMENTIA’.
HC MCI AD MD VD Other Total
N 42 47 33 37 10 10 179
Age 72.5 ± 8.3 76.6 ± 7.7 79.2 ± 5.0 78.8 ± 7.5 78.6 ± 4.6 78.1 ± 7.2 76.8 ± 7.5
Sex 8M/34F 23M/24F 12M/21F 19M/18F 8M/2F 10M/10F 80M/109F
MMSE 28.3 ± 1.6 26.0 ± 2.5 18.9 ± 5.0 18.5 ± 4.7 20.2 ± 4.1 23.7 ± 4.8 23.2 ± 5.5
CDR-SOB 0.48 ± 0.68 1.68 ± 1.11 7.52 ± 3.95 8.05 ± 3.31 5.50 ± 4.16 3.03 ± 3.63 4.02 ± 4.16
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Fig. 2. Histograms of MMSE and CDR-SOB scores with cut-off values for staging are indicated by dotted lines.
the NINCDS-ADRDA criteria [41]. Mixed/Vascular dementia
were diagnosed according to ICD 10 [42] criterea. For the
MCI group, diagnosis was conducted according to Petersen
criteria [43]. Participants were excluded if they had any
major auditory or language problems, history of head trauma,
loss of consciousness, psychotic or aberrant motor behaviour.
Demographic data and clinical test results by diagnostic groups
are reported in Table I.
The distribution of clinical scores in the data is shown in
Figure 2. The left figure shows MMSE scores, which range
from 0 (worst) to 30 (best). The most commonly used cut-off
in the literature for possible dementia is 24. Other cut-offs
include 17, 18, 19, 23, 25, and 26 [44]. Fewer than 10 of our
participants fall below the lowest cut-off, while roughly half
of them are below the traditional cut-off.
The right figure shows CDR-SOB scores, which range from
0 (normal) to 18 (worst). The stages of dementia severity
corresponding to CDR-SOB scores are described in Table II
(adapted from [2]). Again, most subjects are staged as normal
or having possible impairment, and only few have moderate
or severe dementia.
B. Features
In the following we describe which features have been
computed for each sample. We compute features from three
different categories: Statistical Clustering and Switching, Word
Frequency Features, and Vocal Features.
Let a1, a2, . . . , an be the sequence of animals produced by
TABLE II
CUT-OFF VALUES FOR THE CDR-SOB ACCORDING TO [2].
CDR SOB Staging
0 normal
0.5 – 4.0 possible impairment or very mild dementia
4.5 – 9.0 mild dementia
9.5 – 15.5 moderate dementia
16.0 – 18.00 severe dementia
patient p, with ai ∈ A and A being the set of all animals.
Word Count
WC = n
Statistical Clustering and Switching
We compute features based on using word embeddings
calculated with word2vec [45] based on the french FraWac
corpus [46] as described in [31]. Let ~a1, ~a2, . . . , ~an be their
representations in the vector space and let a1, . . . , an−1 form
a semantic cluster. an is part of this cluster if
| 〈~µ, ~an 〉‖~µ‖ · ‖ ~an ‖ | > δp
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Fig. 3. Visualisation of feature distribution in relation to MMSE and CDR-SOB.
with
~µ =
1
n− 1 ·
∑
~x∈{ ~a1,..., ~an−1}
~x
δp =
n!
(n− 2)! ·
∑
~x,~y∈{ ~a1,..., ~an}
| 〈~x, ~y 〉‖~x‖ · ‖~y ‖ |
Let c1,c2, . . . , cm be the sequence of clusters, determined
as described above and let |ci| be their size. We compute the
following metrics:
Semantic Density
SD = δp
Mean Cluster Size
MCS =
1
m
m∑
i=1
|ci|
Number of Switches
NOS = m− 1
TABLE III
PEARSON CORRELATION OF MMSE, CDR-SOB AND COMPUTED FEATURES.
MMSE CDR-SOB WC MCS NOS MWF SD MPL
MMSE 1.000 -0.834*** 0.602** -0.176 0.486* -0.560** -0.552** -0.352*
CDR-SOB 1.000 -0.569** 0.226 -0.464* 0.550** 0.553** 0.306*
WC 1.000 -0.123 0.838*** -0.514** -0.538** -0.398*
MCS 1.000 -0.335* 0.191 0.339* 0.006
NOS 1.000 -0.370* -0.511** -0.376*
MWF 1.000 0.642** 0.311*
SD 1.000 0.399*
MPL 1.000
* |σ| > 0.3 ** |σ| > 0.5 *** |σ| > 0.7
Word Frequency
We approximate word frequency of animals using the
Python wordfreq package [47], which combines resources
such as Wikipedia, news and book corpora and Twitter. Let
f : A→ R be the function mapping a word to its frequency.
Mean Word Frequency
MWF =
1
n
n∑
i=1
f(ai)
Vocal Features
Let p1, p2, . . . ,ps be the pauses in the audio sample, deter-
mined using the Praat software [48] as intervals of absence of
sound longer than 250 ms. Let |pi| be the length of a pause.
Mean Pause Length
MPL =
1
s
s∑
i=1
|pi|
C. Evaluation Criterion
For evaluation of the quality of prediction of regression
models there are many different metrics. Popular for its
mathematical sophistication and severe punishment for large
errors is the Root Mean Squared Error (RMSE).
In our case the use of the Mean Absolute Error (MAE)
seems more appropriate. It delivers interpretable results on the
real error made by the predictive model, scaled in the same
way the clinical scores are. Let yi be the actual value of sample
i, let yˆi be the regression models prediction and N the number
of samples. The MAE is defined as
MAE =
1
N
N∑
i=1
|yˆi − yi|
In the following we will describe the results of regression
models and discuss the implications of their predictions.
IV. EXPERIMENTS
In order to determine the importance of and relationship
between MMSE, CDR-SOB and the computed features we
examine correlations, reported in Table III, and look at scatter
plots of features and MMSE/CDR-SOB in Figure 3. Corre-
lations smaller than 0.3 are considered as weak, greater than
0.5 as moderate and greater than 0.7 as strong. Both MCS
and MCL have weak correlations to MMSE and CDR-SOB.
Looking at their respective scatter plot, MCS does not seem to
have any predictive power for either score, whereas the MPL
seems to have at least some. Therefore, we exclude MCS from
our feature set for all further analysis. WC, MWF and SD
have correlations greater than 0.5 with both MMSE and CDR.
Inspection of their respective scatter plots shows a near linear
relationship.
To predict the CDR-SOB and MMSE, we train different
regression models and evaluate their performance using MAE.
A. Prediction
Regression models are trained including Support Vector
Regression (SVR), Lasso (Linear Regression with L1 reg-
ularisation), Ridge Regression (Linear Regression with L2
regularization), Elastic Net (EN) and a Random Forest Re-
gressor (RFR). Their implementations are provided by the
scikit-learn python framework [49] and all are trained with the
features described in Section III-B excluding MCS. Features
are normalised by subtraction of their mean and division
through their standard deviation. Because of the small data
set size (n=179) we can not use a separate validation/test set.
Instead we rely on averaging multiple shuffled k-Fold cross
validations, with k set to 5. Hyper parameters are determined
using a cross validation based grid search on the training folds
in each iteration of the outer cross validation loop.
Results of the regression are reported in Table IV. The RFR
shows the worst performance of all tested regression models.
For prediction of the CDR-SOB all other models (SVR, LR-
L1, LR-L2, EN) show similar performance with overlapping
95% confidence intervals. For the MMSE the RFR also has
the worst performance and the other regressors’ performance
is comparable again. Especially because of the small data set
we are not able to identify any clear best performing model.
In contrast to normal regression, our predicted value is
bound to a discrete scale, we are able to draw a confusion
Fig. 4. Confusion matrix for MMSE and CDR-SOB predictions, as heat-map, obtained using a SVR model and rounding predictions to the nearest scale
values.
TABLE IV
MEAN ABSOLUTE ERROR (MAE) AND 95% CONFIDENCE INTERVALS FOR
DIFFERENT REGRESSION MODELS. BEST PERFORMANCE INDICATED IN
BOLD.
MAEMMSE MAECDR-SOB
SVR 2.205 [1.920, 2.490] 1.670 [1.433, 1.907]
LR - L1 2.274 [1.988, 2.560] 1.683 [1.454, 1.912]
LR - L2 2.289 [1.997, 2.581] 1.715 [1.485, 1.945]
EN 2.286 [1.993, 2.579] 1.688 [1.456, 1.920]
RFR 2.363 [2.073, 2.654] 1.728 [1.469, 1.986]
TABLE V
MEAN ABSOLUTE ERROR (MAE) [95% CONFIDENCE INTERVAL] AND
MEAN ± STANDARD DEVIATION OF MMSE AND CDR-SOB PREDICTION
FOR A SVR MODEL BY DIAGNOSIS GROUP.
µMMSE MAEMMSE µCDR-SOB MAECDR-SOB
HC 28.244 ± 1.523 1.205 [0.905, 1.505] 0.489 ± 0.687 0.808 [0.589, 1.027]
MCI 25.679 ± 2.759 2.175 [1.678, 2.672] 1.708 ± 1.121 1.328 [1.030, 1.626]
DCI 18.914 ± 4.882 2.781 [2.311, 3.251] 7.556 ± 3.843 2.372 [1.955, 2.789]
matrix for each score by rounding predictions to the nearest
value on the respective scale (1 steps for MMSe and 0.5 steps
for CDR-SOB). Figure IV-A shows the confusion matrices
for MMSE and SDR-SOB using predictions from the SVR
model. For predictions of the MMSE score, there seems to be
an underestimation for patients with an MMSE > 24 and an
overestimation for patients with MMSE ≤ 24. Predictions of
the CDR-SOB are overestimating for a CDR-SOB ≤ 3 and
underestimating for CDR-SOB > 3.
To better understand the results we examine the MAE
by diagnosis group. We define three different groups: SCI,
MCI and dementia (DCI). SCI and MCI are diagnosis groups
appearing in our dataset. Anyone with a confirmed diagnosis
of Alzheimer’s disease, Vascular Dementia or Mixed Dementia
is put into the DCI group. The results are listed in Table V.
At first glance it seems like the prediction error is growing
with impairment of patients. But looking at the mean of each
diagnosis group, one can observe that the standard deviation
grows as well - meaning the values are spread further apart.
This increases the complexity of the regression problem and
accounts for the increased error.
B. Clinical Interpretation of Predictions
In practice, clinicians will interpret predicted scores relative
to the interpretation framework they use for the actual tests.
Therefore, we translated the continuous predicted test scores
into categorical judgements and compared these judgments to
those made on the original values using Cohen’s unweighted
κ [50] to measure agreement. For each case, we used the
predicted value where the case was part of the test cross
validation fold, not the training folds. A total of 179 cases
with predicted CDR-SOB and MMSE values were available.
κ was computed using the R package psych, Version 1.7.5.
κ =
agreementobserved − agreementexpected
1− agreementexpected
Since the predicted scores are continuous, we devised two
strategies for mapping them onto the discrete scores required
for decision making. For the MMSE, we used a strict cut-
off, where all values smaller than the boundary value indicate
possible dementia, and a cut-off that rounds the predicted value
to the nearest integer. For CDR-SOB, we used a strict cut-off
that mapped values in between two category boundaries onto
the category indicating less impairment, and a cut-off where
values are rounded to the nearest 0.5.
Reliability for CDR-SOB is not very high—the best agree-
ment is 0.52, and there is a lot of overlap in the 95% con-
fidence intervals (Table VI). As the confusion matrix shows,
this is due to a tendency to slip into the next higher or next
lower category. While this does not seem critical at first, in
clinical practice, misdiagnosis in either direction can be highly
problematic [51].
For the MMSE, however, agreement is much better. De-
pending on the threshold and the cut-off mechanism used, κ
H
ea
lth
y
Im
pa
ire
d
Predicted Category
Healthy
ImpairedT
ru
e 
C
at
eg
or
y 55 6
14 104
10
20
30
40
50
60
70
80
90
100
N
or
m
al
V
er
y 
M
ild
M
ild
M
od
er
at
e
S
ev
er
e
Predicted Stage
Normal
Very Mild
Mild
Moderate
Severe
Tr
ue
 S
ta
ge
14 10
8 66 14 1
11 30 10
2 11 1
1
0
8
16
24
32
40
48
56
64
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TABLE VI
κ FOR CDR-SOB STAGING, DIFFERENT CUT-OFF STRATEGIES.
ESTIMATED VALUE WITH 95% CONFIDENCE INTERVAL. BEST
PERFORMANCE INDICATED IN BOLD.
Cut-Off κ
Strict 0.47 [0.36, 0.57]
Rounded 0.52 [0.41, 0.62]
TABLE VII
κ FOR MMSE STAGING, ROUNDING TO NEAREST INTEGER. ESTIMATED
VALUE WITH 95% CONFIDENCE INTERVAL. BEST PERFORMANCE
INDICATED IN BOLD.
Threshold κ
17 0.59 [0.40, 0.78]
23 0.76 [0.66, 0.86]
24 0.74 [0.64, 0.84]
26 0.64 [0.53, 0.75]
varies between 0.59 (95% CI [0.4, 0.77]) for a threshold of 17
and 0.76 (95% CI [0.66, 0.86]) for a threshold of 23. Table VII
shows agreement values for four thresholds, 17 (lowest), 23
(best), 24 (traditional), and 26 (highest), using the rounding
strategy to match thresholds. As we can see from the confusion
matrix, decisions based on the MMSE scores estimated by our
approach would lead to slightly more people being screened.
V. DISCUSSION
A. Translation Into Clinical Practice
In principle, it is desirable to detect dementia at an early
stage, so that the person with the disease and their family
can take steps to maximise their quality of life. However,
coming to terms with a diagnosis of dementia can be very
difficult [52], [53]. Even if a person is referred for additional
screening on the basis of a test such as the MMSE, and is
found to be healthy, there can be negative consequences, such
as people taking screening results less seriously, or becoming
more anxious to bother their doctor for nothing [51], [54].
Therefore, once we have established that a machine learning
approach has promise, we need to consider how it is best
integrated into practice to avoid unnecessary harm.
While SVF clearly contains some information that can be
useful when establishing the stage of a person’s dementia, the
most promising results are those for predicting MMSE scores.
This makes sense clinically, as SVF does not reflect all of the
dimensions on which people with dementia can be impaired,
and the trajectory of decline can be very different depending
on the person and the subtype of dementia they have.
At the moment, for the MMSE, we achieve good agreements
with traditional judgements using manual features. Problems
might arise when automating the scenario. [55] saw the per-
formance of their classifiers deteriorate when using Automatic
Speech Recognition (ASR) but this is likely to improve as ASR
modules are specially developed for clinical data.
Since administering SVF requires minimal training, this
makes the test ideal for deployment in a telehealth scenario.
Recordings of patients can be obtained by carers, case workers,
social workers, and nurses, and they can take place in a quiet
room in the patient’s home or a convenient clinic room. After
automatic analysis, the results can be sent automatically to the
patient’s General Practitioner and their specialist geriatrician
or old age psychiatrist.
It is even possible to fully automate the SVF test as part
of an in-home kiosk or tablet app. However, for this use case,
algorithms would need to be calibrated with additional training
data, as people with moderate to severe dementia may find it
difficult to follow the instructions of an automated app.
VI. CONCLUSION AND FUTURE WORK
In this paper, we explored the possibility to predict MMSE
and CDR-SOB scores based on linguistic and vocal features
extracted from a SVF task. We were able to train a regression
model with a MAE of 2.2 for the MMSE and 1.7 for the CDR-
SOB. We discussed how these predictions could be used in
clinical practice and that the agreement of MMSE predictions
and real scores were high enough for a potential use as a
screening tool. For predictions of the CDR-SOB the SVF task
does not seem to capture all dimensions of impairment found
in dementia.
These promising results are first steps in the direction of
formulating diagnosis and cognitive assessment as a regression
problem. To additionally reliably predict severity of dementia
progression, in-depth analysis of more than one cognitive test
might be needed.
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